Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

INFORMATION SERVICES GROUP INC. (III)

  • Business News
  • May 06, 2026, 22:10 UTC
  • 4
  • 1 comments

Imperial Reports First Quarter 2026 Financial Results

Market reaction Comment Full text

ALPHATEC HOLDINGS, INC. (ATEC)

  • Business News
  • May 06, 2026, 22:09 UTC
  • 4
  • 1 comments

Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Alphatec Holdings, Inc.

Market reaction Comment Full text

PRIMORIS SERVICES CORP (PRIM)

  • Business News
  • May 06, 2026, 22:07 UTC
  • 4
  • 1 comments

Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Primoris Services Corporation

Market reaction Comment Full text

TKO GROUP HOLDINGS, INC. (TKO)

  • Business News
  • May 06, 2026, 22:07 UTC
  • 4
  • 1 comments

Taseko Announces Continued Strong Operational and Financial Results in the First Quarter 2026

Market reaction Comment Full text

DaVita HealthCare Partners Inc (DVA)

  • Business News
  • May 06, 2026, 22:03 UTC
  • 4
  • 1 comments

DaVita Inc. to Participate in the BofA Securities 2026 Health Care Conference

Market reaction Comment Full text

GOLD RESERVE LTD. (BERMUDA) (GDRZF)

  • Business News
  • May 06, 2026, 22:02 UTC
  • 4
  • 1 comments

Gold Reserve anuncia la escisión de American Heralds Mining Corporation, una nueva minera con sede en EE. UU. orientada al desarrollo de recursos en el hemisferio occidental y alineada con la estrategia estadounidense de minerales críticos

Market reaction Comment Full text

TENARIS SA (TS)

  • Business News
  • May 06, 2026, 22:02 UTC
  • 4
  • 1 comments

Tenaris anuncia la sucesión de su CEO

Market reaction Comment Full text

TENARIS SA (TS)

  • Business News
  • May 06, 2026, 22:02 UTC
  • 3
  • 1 comments

Tenaris Announces CEO succession

Market reaction Comment Full text

DAVITA INC. (DVA)

  • Business News
  • May 06, 2026, 22:01 UTC
  • 4
  • 1 comments

DaVita Inc. to Participate in the BofA Securities 2026 Health Care Conference

Market reaction Comment Full text

Revolution Medicines Inc (RVMDW)

  • Business News
  • May 06, 2026, 22:00 UTC
  • 4
  • 1 comments

Revolution Medicines Announces Publication in New England Journal of Medicine of Phase 1/2 Clinical Data on Daraxonrasib in Pancreatic Cancer

Market reaction Comment Full text
  • Previous
  • 544
  • 545
  • 546
  • 547
  • 548
  • Next

Search

News categories

  • Technical Exchange News(12514)
  • Event(6229)
  • SEC News(284263)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(162147)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin